Abstract:Bioinformatics is a rapidly growing field involving the application of computational methods to the analysis and interpretation of biological data. An important task in bioinformatics is the identification of novel drug-target interactions (DTIs), which is also an important part of the drug discovery process. Most computational methods for predicting DTI consider it as a binary classification task to predict whether drug target pairs interact with each other. With the increasing amount of drug-target binding affinity data in recent years, this binary classification task can be transformed into a regression task of drug-target affinity (DTA), which reflects the degree of drug-target binding and can provide more detailed and specific information than DTI, making it an important tool in drug discovery through virtual screening. Effectively predicting how compounds interact with targets can help speed up the drug discovery process. In this study, we propose a deep learning model called TC-DTA for the prediction of the DTA, which makes use of the convolutional neural networks (CNN) and encoder module of the transformer architecture. First, the raw drug SMILES strings and protein amino acid sequences are extracted from the dataset. These are then represented using different encoding methods. We then use CNN and the Transformer's encoder module to extract feature information from drug SMILES strings and protein amino acid sequences, respectively. Finally, the feature information obtained is concatenated and fed into a multi-layer perceptron for prediction of the binding affinity score. We evaluated our model on two benchmark DTA datasets, Davis and KIBA, against methods including KronRLS, SimBoost and DeepDTA. On evaluation metrics such as Mean Squared Error, Concordance Index and r2m index, TC-DTA outperforms these baseline methods. These results demonstrate the effectiveness of the Transformer's encoder and CNN in the extraction of meaningful representations from sequences, thereby improving the accuracy of DTA prediction. The deep learning model for DTA prediction can accelerate drug discovery by identifying drug candidates with high binding affinity to specific targets. Compared to traditional methods, the use of machine learning technology allows for a more effective and efficient drug discovery process.

GDilatedDTA: Graph dilation convolution strategy for drug target binding affinity prediction

DGDTA: dynamic graph attention network for predicting drug-target binding affinity

A deep learning method for drug-target affinity prediction based on sequence interaction information mining

HGTDP-DTA: Hybrid Graph-Transformer with Dynamic Prompt for Drug-Target Binding Affinity Prediction

GSAML-DTA: An interpretable drug-target binding affinity prediction model based on graph neural networks with self-attention mechanism and mutual information

Drug-Target Affinity Prediction Based on Improved GraphDTA

ColdDTA: Utilizing data augmentation and attention-based feature fusion for drug-target binding affinity prediction

MMD-DTA: A multi-modal deep learning framework for drug-target binding affinity and binding region prediction

DataDTA: a multi-feature and dual-interaction aggregation framework for drug–target binding affinity prediction

TC-DTA: predicting drug-target binding affinity with transformer and convolutional neural networks

AttentionMGT-DTA: A multi-modal drug-target affinity prediction using graph transformer and attention mechanism

GTAMP-DTA: Graph transformer combined with attention mechanism for drug-target binding affinity prediction

G-K BertDTA: A graph representation learning and semantic embedding-based framework for drug-target affinity prediction

Prediction of Drug-Target Affinity Using Attention Neural Network

ImageDTA: A Simple Model for Drug-Target Binding Affinity Prediction

GDGRU-DTA: Predicting Drug-Target Binding Affinity Based on GNN and Double GRU

Learning Long- and Short-term Dependencies for Improving Drug-Target Binding Affinity Prediction using Transformer and Edge Contraction Pooling

Drug–target binding affinity prediction based on three-branched multiscale convolutional neural networks

Enhancing Drug-Target Binding Affinity Prediction through Deep Learning and Protein Secondary Structure Integration

Breaking the barriers of data scarcity in drug–target affinity prediction

AttentionDTA: prediction of drug–target binding affinity using attention model